Ameritas Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $618K | Sell |
4,887
-25,989
| -84% | -$3.29M | 0.03% | 454 |
|
2025
Q1 | $3.96M | Buy |
30,876
+1,782
| +6% | +$229K | 0.16% | 142 |
|
2024
Q4 | $3.85M | Buy |
29,094
+2,508
| +9% | +$332K | 0.13% | 151 |
|
2024
Q3 | $3.87M | Sell |
26,586
-2,334
| -8% | -$340K | 0.17% | 131 |
|
2024
Q2 | $3.97M | Buy |
28,920
+5,940
| +26% | +$815K | 0.15% | 140 |
|
2024
Q1 | $3.1M | Buy |
22,980
+13,269
| +137% | +$1.79M | 0.13% | 173 |
|
2023
Q4 | $1.32M | Sell |
9,711
-3,874
| -29% | -$526K | 0.07% | 234 |
|
2023
Q3 | $1.64M | Buy |
13,585
+3,840
| +39% | +$462K | 0.08% | 233 |
|
2023
Q2 | $1.21M | Sell |
9,745
-1,721
| -15% | -$214K | 0.16% | 151 |
|
2023
Q1 | $1.5M | Sell |
11,466
-2,134
| -16% | -$278K | 0.08% | 244 |
|
2022
Q4 | $1.79M | Buy |
13,600
+2,336
| +21% | +$307K | 0.08% | 238 |
|
2022
Q3 | $1.32M | Buy |
11,264
+2,442
| +28% | +$286K | 0.08% | 237 |
|
2022
Q2 | $1.04M | Sell |
8,822
-650
| -7% | -$76.5K | 0.06% | 281 |
|
2022
Q1 | $1.23M | Buy |
9,472
+483
| +5% | +$62.9K | 0.05% | 293 |
|
2021
Q4 | $1.37M | Buy |
+8,989
| New | +$1.37M | 0.05% | 279 |
|